StockWatch
·
Services-Commercial Physical & Biological Research
Quarterly ResultMay 15, 2026, 11:03 AM

FOXO Technologies Q1 Revenue +63% to $5.17M; Net Loss Widens

AI Summary

FOXO Technologies reported a significant increase in net revenues for Q1 2026, reaching $5.17 million, a 63% rise from the previous year. However, the company's net loss attributable to FOXO widened to $1.45 million, up from $0.62 million in Q1 2025. The company continues to face substantial doubt about its ability to continue as a going concern, citing a history of losses, a $27.1 million working capital deficit, and low cash reserves, despite improvements in cash used in operating activities.

Key Highlights

  • Net revenues increased 63% to $5.17 million for Q1 2026, up from $3.17 million in Q1 2025.
  • Net loss attributable to FOXO widened to $1.45 million in Q1 2026 from $0.62 million in Q1 2025.
  • Net loss to common stockholders increased to $1.74 million in Q1 2026 from $1.10 million in Q1 2025.
  • Cash and cash equivalents decreased to $65,896 as of March 31, 2026, from $207,453 at year-end 2025.
  • Working capital deficit stood at $27.1 million as of March 31, 2026.
  • Cash used in operating activities improved to $0.58 million in Q1 2026 from $1.34 million in Q1 2025.
  • Company faces substantial doubt about its ability to continue as a going concern.